An academic researcher's guide to increased impact on regulatory assessment of chemicals

被引:14
作者
Agerstrand, Marlene [1 ]
Sobek, Anna [1 ]
Lilja, Karl [2 ]
Linderoth, Maria [2 ]
Wendt-Rasch, Lina [3 ]
Wernersson, Ann-Sofie [4 ]
Ruden, Christina [1 ]
机构
[1] Stockholm Univ, Dept Environm Sci & Analyt Chem ACES, SE-10691 Stockholm, Sweden
[2] Swedish Environm Protect Agcy, SE-10648 Stockholm, Sweden
[3] Swedish Chem Agcy KemI, SE-17213 Sundbyberg, Sweden
[4] Swedish Agcy Marine & Water Management SwAM, SE-40439 Gothenburg, Sweden
关键词
ENVIRONMENTAL RISK-ASSESSMENT; REDUCING WASTE; EUROPEAN-UNION; OF-INTEREST; SCIENCE; POLICY; TRANSPARENCY; QUALITY; HEALTH; PHARMACEUTICALS;
D O I
10.1039/c7em00075h
中图分类号
O65 [分析化学];
学科分类号
070302 ; 081704 ;
摘要
The interactions between academic research and regulatory assessment of chemicals may in theory seem straightforward: researchers perform studies, and these studies are used by regulators for decision-making. However, in practice the situation is more complex, and many factors decide a research study's regulatory use. According to several EU chemical legislations, all available and relevant studies can be used in hazard and risk assessment of chemicals. However, in practice, standard tests conducted under GLP and sponsored and provided by industry are predominantly used. Peer-reviewed studies from independent sources are often disregarded or disputed since they often do not comply with regulatory data requirements and quality criteria. To help bridge such a gap, the aim of this paper is to give an overview of the general workings of legislation of chemicals and propose a set of actions to increase the usability of research data. In the end, this may increase the use of academic research for decision-making and ultimately result in more science-based policies. From a policy perspective, useful scientific evidence comprises those studies that are sufficiently reliable and relevant. This is not in contradiction to the aims of research and generally accepted scientific standards.
引用
收藏
页码:644 / 655
页数:12
相关论文
共 101 条
[1]  
Abdel-Sattar Maher, 2014, Evid Based Preclin Med, V1, P11
[2]   The Swedish Environmental Classification and Information System for Pharmaceuticals - An empirical investigation of the motivations, intentions and expectations underlying its development and implementation [J].
Agerstrand, M. ;
Wester, M. ;
Ruden, C. .
ENVIRONMENT INTERNATIONAL, 2009, 35 (05) :778-786
[3]   Improving Environmental Risk Assessment of Human Pharmaceuticals [J].
Agerstrand, Marlene ;
Berg, Cecilia ;
Bjorlenius, Berndt ;
Breitholtz, Magnus ;
Brunstrom, Bjorn ;
Fick, Jerker ;
Gunnarsson, Lina ;
Larsson, D. G. Joakim ;
Sumpter, John P. ;
Tysklind, Mats ;
Ruden, Christina .
ENVIRONMENTAL SCIENCE & TECHNOLOGY, 2015, 49 (09) :5336-5345
[4]   Comparison of four different methods for reliability evaluation of ecotoxicity data: A case study of non-standard test data used in environmental risk assessments of pharmaceutical substances [J].
Ågerstrand M. ;
Breitholtz M. ;
Rudén C. .
Environmental Sciences Europe, 23 (1)
[5]   Bad Reporting or Bad Science? Systematic Data Evaluation as a Means to Improve the Use of Peer-Reviewed Studies in Risk Assessments of Chemicals [J].
Agerstrand, Marlenea ;
Edvardsson, Linnea ;
Ruden, Christina .
HUMAN AND ECOLOGICAL RISK ASSESSMENT, 2014, 20 (06) :1427-1445
[6]   Are standard tests sensitive enough to evaluate effects of human pharmaceuticals in aquatic biota? Facing changes in research approaches when performing risk assessment of drugs [J].
Aguirre-Martinez, G. V. ;
Owuor, M. A. ;
Garrido-Perez, C. ;
Salamanca, M. J. ;
Del Valls, T. A. ;
Martin-Diaz, M. L. .
CHEMOSPHERE, 2015, 120 :75-85
[7]   Understanding the mismatch between the demands of risk assessment and practice of scientists - The case of Deca-BDE [J].
Alcock, Ruth E. ;
MacGillivray, Brian H. ;
Busby, Jerry S. .
ENVIRONMENT INTERNATIONAL, 2011, 37 (01) :216-225
[8]  
[Anonymous], ECHA13A01EN
[9]  
[Anonymous], LATE LESSONS EARLY W
[10]  
[Anonymous], EMEACHMPSWP444700